(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GENOMADIX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GENOMADIX

ST13

US500000097978761

Class

1, 5, 9, 10

Filing

97978761

Registration

7647631

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

55

Latest update

01/14/2025

Trademark type

Word

Nice classes

1, 5, 9, 10

Filing date

10/13/2021

Registration date

01/14/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/14/2025

Last transaction

01/14/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

First use anywhere

09/30/2021

First use in commerce

07/31/2023

Drawing code

4

Owner type

99

Owner location

Kanata, Ontario, CA

Examiner

RIBAUDO, MICHELLE

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Genomadix Inc.

Representatives

Sara M. Bauer Womble Bond Dickinson (US) LLP

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Diagnostic reagents for medical and scientific research purposesnot for medical use

Class 5

Clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic reagents for clinical medical laboratory use; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluid; reagents for use in medical genetic testing; swabs for medical purposes

Class 9

Biomedical diagnostic apparatusfood and water safety testing for environmental monitoring; biomedical diagnostic apparatusmolecular diagnostic device used for nucleic acid testinginfectious disease testinggenetic testingdrug response testing for environmental monitoring for research purposes; biomedical devices in the nature of cartridges for loading biological samples for use in molecular diagnostic devices other than for medical use; testing sample collection equipmentswabs for obtaining biological samples from subjects for research purposes

Class 10

Biomedical diagnostic apparatusmolecular diagnostic device used for nucleic acid testinginfectious disease testinggenetic testingdrug response testing for medical monitoring purposes; biomedical diagnostic devices in the nature of cartridges for loading biological samples for use in molecular diagnostic devices for medical purposes; medical devices for obtaining body fluid samples in the nature of testing sample collection equipment comprised of swabs for obtaining biological samples from subjects for biomedical purposes

Publications

History of USPTO decisions and trademark events.

55 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/14/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/14/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/26/2024

PUBO

PUBLISHED FOR OPPOSITION

11/26/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/20/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/01/2024

IUAA

USE AMENDMENT ACCEPTED

11/01/2024

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

10/30/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

10/23/2024

GNSL

LETTER OF SUSPENSION E-MAILED

10/23/2024

CNSL

SUSPENSION LETTER WRITTEN

10/23/2024

ALIE

ASSIGNED TO LIE

10/22/2024

DPCC

DIVISIONAL PROCESSING COMPLETE

09/04/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/12/2024

DOCK

ASSIGNED TO EXAMINER

07/25/2024

IUAF

USE AMENDMENT FILED

06/17/2024

DRRR

DIVISIONAL REQUEST RECEIVED

06/17/2024

EAAU

TEAS AMENDMENT OF USE RECEIVED

06/17/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

06/17/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/31/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/31/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/30/2024

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

03/20/2024

GNSI

INQUIRY TO SUSPENSION E-MAILED

03/20/2024

CNSI

SUSPENSION INQUIRY WRITTEN

03/20/2024

DOCK

ASSIGNED TO EXAMINER

03/20/2024

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/26/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/07/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/07/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/07/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/07/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/07/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

08/24/2023

GNSL

LETTER OF SUSPENSION E-MAILED

08/24/2023

CNSL

SUSPENSION LETTER WRITTEN

08/24/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/16/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/16/2023

ALIE

ASSIGNED TO LIE

08/16/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/05/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

04/03/2023

GNSI

INQUIRY TO SUSPENSION E-MAILED

04/03/2023

CNSI

SUSPENSION INQUIRY WRITTEN

04/03/2023

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

03/30/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

08/27/2022

GNSL

LETTER OF SUSPENSION E-MAILED

08/27/2022

CNSL

SUSPENSION LETTER WRITTEN

08/27/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/17/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/16/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/16/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/22/2022

GNRT

NON-FINAL ACTION E-MAILED

07/22/2022

CNRT

NON-FINAL ACTION WRITTEN

07/22/2022

DOCK

ASSIGNED TO EXAMINER

07/19/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/03/2021

NWAP

NEW APPLICATION ENTERED

10/16/2021

Continuous trademark protection

Get notified about every new filing that threatens GENOMADIX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.